Fmr LLC Decreases Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

FMR LLC lowered its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 0.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,290,116 shares of the company's stock after selling 39,723 shares during the period. FMR LLC owned 6.06% of HealthEquity worth $432,996,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Raymond James Trust N.A. grew its position in HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company's stock worth $238,000 after buying an additional 132 shares in the last quarter. Truist Financial Corp grew its holdings in shares of HealthEquity by 7.0% during the second quarter. Truist Financial Corp now owns 2,864 shares of the company's stock worth $247,000 after purchasing an additional 188 shares in the last quarter. Nisa Investment Advisors LLC increased its position in shares of HealthEquity by 7.5% in the second quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company's stock worth $246,000 after purchasing an additional 198 shares during the last quarter. Elk River Wealth Management LLC increased its position in shares of HealthEquity by 0.3% in the third quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company's stock worth $5,417,000 after purchasing an additional 217 shares during the last quarter. Finally, Nicolet Advisory Services LLC raised its stake in HealthEquity by 5.8% in the third quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company's stock valued at $330,000 after purchasing an additional 233 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Bank of America boosted their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research note on Wednesday, November 13th. JMP Securities restated a "market outperform" rating and set a $105.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. BTIG Research lifted their price target on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research note on Thursday, November 14th. Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $107.23.

Insiders Place Their Bets

In other news, Director Frank Corvino sold 1,039 shares of the company's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now directly owns 3,784 shares of the company's stock, valued at $363,642.40. This represents a 21.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the business's stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 13.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 10,536 shares of company stock worth $884,517 over the last three months. Company insiders own 2.20% of the company's stock.

HealthEquity Trading Down 0.9 %

Shares of HealthEquity stock traded down $0.93 during trading on Friday, reaching $101.54. 452,817 shares of the stock were exchanged, compared to its average volume of 625,647. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a market cap of $8.87 billion, a price-to-earnings ratio of 84.62, a price-to-earnings-growth ratio of 1.60 and a beta of 0.52. HealthEquity, Inc. has a 1 year low of $62.10 and a 1 year high of $105.82. The stock's fifty day moving average is $90.16 and its 200 day moving average is $82.76.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The business had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. As a group, equities research analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.